DNA vaccines;Revue les vaccins à ADN

Annales Pharmaceutiques Francaises

Volumn 61, Issue 4, 2003, Pages 219-233

  Prugnaud, J L ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Adjuvants; Clinical trials; Immunity; Theoretical risks

Indexed keywords

ANTIGEN; DNA VACCINE;

AUTOIMMUNITY; B LYMPHOCYTE; CELLULAR IMMUNITY; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LUPUS ERYTHEMATOSUS; MALARIA; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIDE EFFECT; TH1 CELL; TH2 CELL; TUBERCULOSIS; VACCINATION; ANIMAL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY;

ANIMALS; HUMANS; IMMUNE TOLERANCE; VACCINES, DNA;

EID: 0042466675     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Eloit M. Vaccins traditionnels et vaccins recombinants. INRA Prod Anim 1998; 11: 5-13.
2. McGhee JR, Kyono H. New perspectives in vaccine development: mucosal immunity to infections. Infect Agents Dis 1993; 2: 55-73.
3. Michel ML, Loirat D. Les vaccins à base d'ADN, mt 2000; 6 (4): 310-8.
4. Wolff JA et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-8.
5. Tang D, De Vit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992; 356: 152-4.
6. Ulmer JB, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 1745-9.
7. Scheerlinck J-PY. Genetic adjuvants for DNA vaccines. Vaccine 2001; 19: 2647-56.
8. Leimer W W, Ying H, Driver DA et al. Enhancement of tumor-specific immune response with plasmid DNA replicon vector. Cancer Research 2000; 60: 51.
9. Chen C-H, Wang T-L, Hung C-F et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Research 2000; 60: 1035-42.
10. Gallican WS, Woolstencroft RN, Guatasci T et al. Intranassal immunization with CpG oligonucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract. J Immunol 2001; 166: 3451-7.
11. Drabner B, Guzman CA. Elicitation of predictable immune responses by using live bacterial vectors. Biomol Eng 2001; 17: 75-82.
12. Hsu K F, Hung CF, Cheng WF et al. Enhancement of suicidal DNA vaccine potency by linking of Mycobacterium tuberculosis antigen Heat Shock Protein70 to an antigen. Gene Ther 2001; 8: 376-83.
13. Gentschev I, Dietrich G, Kolb-Maurer A et al. Recombinant attenuated bacteria for delivery of subunit vaccines. Vaccine 2001; 19: 2621-8.
14. Kim JJ, Yang JS, Dentchev T et al. Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines. J of interferon & Cytokine Research 2000; 20 (5): 487-98.
15. Prazeres DMF, Monteiro GA, Ferreira GNM et al. Purification of plasmids for gene therapy and DNA vaccination. Biotechnology Annual review 2001; 7: 1-30.
16. Mena A, Andrew ME, Coupar BE. Rapid dissemination of IM inoculated DNA vaccine. Immunol Cell Biol 2001; 79: 87-9.
17. Okada E, Sasaki S, Ishii N et al. Intranasal immunization of a DNA vaccine with II-12 and granulocyte-macrophage colony stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol 1997; 159 (7): 3638-47.
18. Vajdy M, O'Hagan DT. Microparticles for intranasal immunization. Advanced Drug Delivrery Reviews 2001; 51: 127-41.
19. Oh Y-K, Kim J-P, Hwang TS et al. Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery. Vaccine 2001; 19: 4519-25.
20. Singh M, Briones M, Ott G et al. Cationic microparticles: a potent delivery system for DNA vaccines. PNAS 2000; 97 (2): 811-6.
21. Bachy M, Boudet F, Girerd-Chambaz Y et al. Electric pulses increase the immunogenicity of an influenza DNA vaccine injected IM in the mouse. Vaccine 2001; 19: 168-893.
22. Ogra PL, Faden H, Welliver RC. Vaccination strategies for mucosal immune responses. Clin Microbiol rev 2001; 14: 430-45.
23. Eo SK, Gierynska M, Kamar AA, Rouse BT. Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules. J Immunol 2001; 166: 5473-9.
24. Perrie Y, Frederik PM, Gregoriadis G. Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine 2001; 19: 3301-10.
25. Whalen RG. DNA vaccines for emerging infectious diseases: what if?. Emerging Infectious Diseases 1996; 2 (3): 168-75.
26. Michel ML, Loirat D. DNA vaccines for prophylactic or therapeutic immunization against hepatitis B. Intervirology 2001; 44: 78-87.
27. Michel ML, Davis HL, Scheef M, Mancini M et al. DNA-mediated immunization to hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA 1995; 92: 5307-11.
28. Sin J-I, Weiner DB. Improving DNA vaccines targeting viral infection. Intervirology 2000; 43: 233-46.
29. Sharma AK, Khuller GK. DNA vaccines: future strategies and relevance to intracellular pathogens. ImmunoIogy and Cell Biology 2001; 79: 537-46.
30. Torres CAT, Iwasaki A, Barber B, Robinson HL. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol 1997; 158: 4529-32.
31. Akbari O, Panjwani N, Garcia S et al. DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J Exp Med 1999; 189: 169-77.
32. Roman M et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 3: 849-54.
33. Porgador A PL. DNA-based vaccines: role of dendritic cells in antigen presentation. Advanced in Experimental medicine & Biology 2000; 479: 175-84.
34. Gurunathan S, Wu CY, Freidag BL, Seder RA. DNA vaccines: a key for inducing long-term cellular immunity. Current Opinion in Immunology 2000; 12 (4): 442-7.
35. Carayanniotis G, Barber BH. Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC. Nature 1987; 327: 59-61.
36. Boyle JS, Brady JL, Lew AM. Enhanced responses to a DNA vaccine encoding a fusion antigen that is direct to sites of immune induction. Nature 1998; 392 (6674): 408-11
37. Chaplin PJ, de Rose R, Boyle JS, et al. Targeting improves the efficacy of a DNA vaccine against Coruynebacterium pseudotuberculosis in sheep. Infect Immun; 1999; 67 (12): 6434-8.
38. Deliyannis G, Boyle JS, Brady JL, Brown LE, Lew AM. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. Proc Natl Acad Sci USA 2000; 97 (12): 6676-80.
39. Weiss R, Scheiblhofer S, Freund J et al. Gene gun bombardment with gold articles displays a particular Th2-promoting signal that over-rules the Thl-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine 2002; 20: 3148-54.
40. Robinson HL. New Hope for an AIDS vaccine. Nature Reviews 2002; 2: 239-50.
41. Mitsuyasu RT. AIDS Vaccine 2001: looking to the future (conference report). Medscape HIV/AIDS eJournal 2001; 7 (5).
42. Novak K, MacFarlane J, Aamodt S. AIDS vaccines advance. NatMed 2000; 6: 1220.
43. Shen X, Siliciano RF. Preventing AIDS but not HIV-1 infection with a DNA vaccine. Science 2000; 290: 463-5.
44. Smith JM, Leung NJ, Torres JV. Preparation and induction of immune responses by a DNA AIDS vaccine. Viral Immunol 2000; 13: 343-51.
45. Amara RR, Villinger F, Altman JD, Lydy SL, O'Neil SP, Staprans SI, Montefiori DC et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001; 292: 69-74.
46. Ross TM, Xu Y, Green TD, Montefiori DC, Robinson HL. Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gpl20-C3d fusion proteins. AIDS Res Hum Retroviruses 2001; 17: 829-35.
47. Liu LJ, Watabe S, Yang J, Hamajima K, Ishii N, Hagiwara E, Onari K, Xin KQ, Okuda K. Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses. Vaccine 2001; 20: 42-8.
48. Tadokoro K, Koizumi Y, Miyagi Y, Kojima Y, Kawamoto S, Hamajima K et al. Rapid and wide-reaching delivery of HIV-1 env DNA vaccine by intranasal administration. Viral Immunol 2001; 14: 159-67.
49. Yoshizawa I, Soda Y, Mizuochi T, Yasuda S, Rizvi TA, Takemori T, Tsunetsugu-Yokota Y. Enhancement of mucosal immune response against HIV-1 Gag by DNA immunization. Vaccine 2001; 19: 2995-3003.
50. D'Souzaz S, Rosseels V, Denis O, Tanghe A et al. Improved tuberculosis DNA vaccines by formulation in cationic lipids. Infect Immun 2002; 70 (7): 3681-8.
51. Leon Prieto F, Arguelles Grande C, Bootello Gil A. Immunotherapy prospects in tuberculosis: cytokines and DNA 'vaccines". Rev Clin Esp 2001; 200: 318-22.
52. Lowrie DB, Silva CL. Enhancement of immunocompetence in tuberculosis by DNA vaccination. Vaccine 2001; 18: 1712-6.
53. Collins HL, Kaufmann SH. Prospects for better tuberculosis vaccines. Lancet Infect Dis 2001; 1: 21-8.
54. Orme IM, McMurray DN, Belisle JT. Tuberculosis vaccine development: recent progress. Trends Microbiol 2001; 9: 115-8.
55. Ulmer JB. Tuberculosis DNA vaccines. Scand J Infect Dis 2001; 33: 246-8.
56. Brinster C, Inchauspé G. DNA vaccines for hepatitis C virus. Intervitology 2001; 44: 143-53.
57. Prince AM. Perspectives on prophylactic and therapeutic immunization against hepatitis B and C viruses. Transfus Clin Biol 2001; 8: 467-70.
58. Encke J, Zu Putlitz J, Wands JR. DNA vaccines. Intervirology 1999; 42: 117-24.
59. Rafati S, Salmanian AH, Taheri T, AVafa M, Fasel N. A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major. Vaccine 2001; 19: 3369-75.
60. Perrin P, Jacob Y et al. Immunisation of dogs with a DNA induces protection against rabies virus. Vaccine 1999; 18: 479-86.
61. Daubersies P, Thomas AW, Millet P, Brahimi K P et al. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved preerythrocytic liver-stage antigen 3. Nat Med 2000; 6: 1258-63.
62. Lawrence G, Cheng QQ, Reed C, Taylor D et al. Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers. Vaccine 2000; 18: 1925-31.
63. Chen Z, Kadowaki S, Hagiwara Y, Yoshikawa T, Matsuo K, Kurata T, Tamura S. Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine 2000; 18: 3214-22.
64. Cusi MG, Gluck R. Potential of DNA vaccines delivered by influenza virosomes. Vaccine 2000; 18: 1435.
65. Johnson PA, Conway MA, Daly J, Nicolson C, Robertson J, Mills KH. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. J Gen Virol 2000; 81 Pt 7: 1737-45.
66. Ljungberg K, Wahren B, Almqvist J, Hinkula J, Linde A, Winberg G. Effective construction of DNA vaccines against variable influenza genes by homologous recombination. Virology 2000; 268: 244-50.
67. Watabe S, Xin KQ, Ihata A, Liu LJ et al. Protection against influenza virus challenge by topical application of influenza DNA vaccine. Vaccine 2001; 19: 4434-44.
68. Wong JP, Zabielski MA, Schmaltz FL, Brownlee GG et al. DNA vaccination against respiratory influenza virus infection. Vaccine 2001; 19: 2461-7.
69. Ulmer JB. Influenza DNA vaccines. Vaccine 2002; 20: S74-S76.
70. Palese P, Garcia-Sastre A. Influenza vaccines: present and future. J Clin Invest 2002; 110: 9-13.
71. Cohen EP. Cancer therapy with DNA-based vaccines. Immunol Lett 2000; 74: 59-65.
72. Mincheff M, Tchakarov S, Zoubak S, Loukinov D et al. Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial. Eur Urol 2000; 38: 208-17.
73. Sinkovics JG, Horvath JC. Vaccination against human cancers (review). Int J Oncol 2000; 16: 81-96.
74. Pecher G. DNA-based tumor vaccines. Onkologie 2002; 25 (6): 528-32.
75. Askenase PW. Gee whiz: CpG DNA allergy therapy!. J Allergy Clin Immunol 2000; 106: 37-40.
76. Sato Y, Kasukawa R. DNA vaccines against allergy. Nippon Rinsho 2000; 58: 1307-14.
77. Nguyen MD, Cinman N, Yen J, Horner AA. DNA-based vaccination for the treatment of food allergy. Allergy 2001; 56: 127-30.
78. Manam S, Ledwith BJ, Barnum AB, Troilo PJ et al. Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA. Intervirology 2000; 43: 273-81.
79. Mor G, Eliza M. Plasmid DNA vaccines (review). Molecular Biotechnology 2001; 19: 245-50.
80. Cichutek K. DNA vaccines: development, standardization and regulation. Intervirology 2000; 43: 331-8.